Tempus AI's ECG-PH, its third FDA-cleared cardiovascular device, analyzes a standard 12-lead ECG to flag signs of pulmonary hypertension in symptomatic patients 40 and older.
Anumana's ECG-AI algorithm for cardiac amyloidosis, cleared by the FDA on April 8, 2026, detected the disease with 78.9% sensitivity and 91.2% specificity across a 25,525-patient, four-health-system study.
EchoNext, trained on 700,000 paired ECG-echocardiogram records at NewYork-Presbyterian and Columbia, won FDA clearance on June 22, 2026 to flag six forms of structural heart disease from a routine ECG alone.
CapsoVision's AI Highlights, cleared by the FDA on September 25, 2026, scans tens of thousands of capsule endoscopy frames to flag suspected small bowel bleeding lesions for physician review.
Mexico is piloting AI-assisted mammography reading tools in public clinics to cut the long wait between a screening mammogram and a diagnosis, Al Jazeera reported on October 3, 2026. The push comes as a shortage of radiologists and oncologists leaves many women, especially outside major cities, waiting weeks or months for results.
Bunkerhill Health has won FDA clearance for the first AI algorithm to detect and measure mitral annular calcification on routine chest CT scans ordered for unrelated reasons, such as lung cancer screening. The tool could turn millions of existing scans into opportunities to catch a heart condition linked to higher cardiovascular mortality, though cardiologists say the clinical response to a positive flag still needs to be defined.
Paige Prostate, the first AI-based pathology product ever cleared by the FDA, is being highlighted as a fully autonomous system that improves prostate cancer detection and has now been validated across more than 200 institutions without site-specific recalibration. Pathologists say it's a powerful assistive tool, but caution it isn't a replacement for human review.
Aidoc has secured FDA clearance for the first comprehensive AI triage system built on a single foundation model, bundling 14 acute diagnostic indications into one hospital workflow. The clearance arrives alongside a broader 2026 surge in autonomous AI diagnostic tools, raising both efficiency hopes and new safety questions.
Allegheny Health Network now processes more than 200,000 prior authorizations a year through an AI 'touchless' system with a 96% first-pass approval rate, but a 2026 Oliver Wyman survey found that while 63% of healthcare organizations have adopted AI in revenue cycle operations, only 15% can show a positive return on investment.
Colorado Governor Jared Polis signed SB 26-189 on May 14, 2026, repealing and replacing the state's original AI Act and narrowing its healthcare exemptions so that HIPAA-covered hospitals and insurers are now only shielded for non-employment uses of AI, while stripping mandatory risk assessments and discrimination duties from the law overall.